Movement Alert｜WUXI XDC Falls 4.24% in Regular Trading, Sector-Wide Pressure Weighs on Outsourcing Stocks

Market Focus

Yesterday

On October 13, WUXI XDC fell 4.24% in regular trading, trading at HK$80.65, with turnover of HK$31.78 million. The decline came amid broad weakness in the life sciences tools and services sector, with peers also trading lower.

Within the life sciences tools and services sector where WUXI XDC belongs, Genscript Bio down 10.54%, Insilico down 5.66%, XtalPi down 4.50%, WUXI BIO down 2.94%, and WUXI APPTEC down 1.73%. Goldman Sachs previously assigned a Buy rating with a target price of HK$97.90, highlighting the upcoming first FDA inspection of the Wuxi production facility, but near-term sector sentiment is dominating trading.

WUXI XDC is an investment holding company primarily engaged in providing comprehensive contract research, development, and manufacturing organization services for antibody-drug conjugates and other bioconjugates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/news/1110536280"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110536280\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110536280?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-13 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110536280","market":"us","top_or_hot":-1,"title":"Movement Alert｜WUXI XDC Falls 4.24% in Regular Trading, Sector-Wide Pressure Weighs on Outsourcing Stocks","media":"Market Focus","content":"<p><p>On October 13, WUXI XDC fell 4.24% in regular trading, trading at HK$80.65, with turnover of HK$31.78 million. The decline came amid broad weakness in the life sciences tools and services sector, with peers also trading lower.</p><p>Within the life sciences tools and services sector where WUXI XDC belongs, Genscript Bio down 10.54%, Insilico down 5.66%, XtalPi down 4.50%, WUXI BIO down 2.94%, and WUXI APPTEC down 1.73%. Goldman Sachs previously assigned a Buy rating with a target price of HK$97.90, highlighting the upcoming first FDA inspection of the Wuxi production facility, but near-term sector sentiment is dominating trading.</p><p>WUXI XDC is an investment holding company primarily engaged in providing comprehensive contract research, development, and manufacturing organization services for antibody-drug conjugates and other bioconjugates.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WUXI XDC Falls 4.24% in Regular Trading, Sector-Wide Pressure Weighs on Outsourcing Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WUXI XDC Falls 4.24% in Regular Trading, Sector-Wide Pressure Weighs on Outsourcing Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-13 09:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 13, WUXI XDC fell 4.24% in regular trading, trading at HK$80.65, with turnover of HK$31.78 million. The decline came amid broad weakness in the life sciences tools and services sector, with peers also trading lower.</p><p>Within the life sciences tools and services sector where WUXI XDC belongs, Genscript Bio down 10.54%, Insilico down 5.66%, XtalPi down 4.50%, WUXI BIO down 2.94%, and WUXI APPTEC down 1.73%. Goldman Sachs previously assigned a Buy rating with a target price of HK$97.90, highlighting the upcoming first FDA inspection of the Wuxi production facility, but near-term sector sentiment is dominating trading.</p><p>WUXI XDC is an investment holding company primarily engaged in providing comprehensive contract research, development, and manufacturing organization services for antibody-drug conjugates and other bioconjugates.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1110536280","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110536280","pubTimestamp":1791855573,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 13, WUXI XDC fell 4.24% in regular trading, trading at HK$80.65, with turnover of HK$31.78 million. The decline came amid broad weakness in the life sciences tools and services sector,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"走势警报|无锡XDC常规交易下跌4.24%，全行业压力令外包股承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On October 13, WUXI XDC fell 4.24% in regular trading, trading at HK$80.65, with turnover of HK$31.78 million. The decline came amid broad weakness in the life sciences tools and services sector, with peers also trading lower.Within the life sciences tools and services sector where WUXI XDC belongs, Genscript Bio down 10.54%, Insilico down 5.66%, XtalPi down 4.50%, WUXI BIO down 2.94%, and WUXI APPTEC down 1.73%. Goldman Sachs previously assigned a Buy rating with a target price of HK$97.90, highlighting the upcoming first FDA inspection of the Wuxi production facility, but near-term sector sentiment is dominating trading.WUXI XDC is an investment holding company primarily engaged in providing comprehensive contract research, development, and manufacturing organization services for antibody-drug conjugates and other bioconjugates.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}